Cutting-edge medical morphine rapid test reagent
Taiwan·Risk Class 2·Formosa Biomedical Technology Co., Ltd. Yilan Factory·Registered Oct 15, 2018 – Aug 18, 2028Active- Analysis ID
- ac8b583d59db58acb729a954f8daa6ac
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- TAIWAN ADVANCE BIO-PHARMACEUTICAL INC.
- Intended Use
- This product uses competitive immunochromatography to qualitatively detect morphine in human urine, and the test results can be used for preliminary screening. The morphine threshold standard is set at 300 ng/ml. This product can be used by both individuals and professionals.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3640 嗎啡試驗系統
- Import Information
- Domestic;; Contract manufacturing
- Registration Date
- Oct 15, 2018
- Expiry Date
- Aug 18, 2028
Top companies providing products similar to "Cutting-edge medical morphine rapid test reagent"
Recently registered similar products
Access comprehensive regulatory information for Cutting-edge medical morphine rapid test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ac8b583d59db58acb729a954f8daa6ac and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including TAIWAN ADVANCE BIO-PHARMACEUTICAL INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.